Standard Engineering Technology reports a 41% rise in revenue for Q1 FY2027, as it advances into AI data centre infrastructure and deepens collaborations with Japanese firms, signalling a bold new phase of growth and innovation.
Standard Engineering Technology said its first-quarter results for fiscal 2027 showed a sharp rise in business momentum, with total income up 41% year on year and profit after tax up 26%. The company’s management presented the figures as evidence that its core engineering franchise remains strong, even as it begins to push into newer, more ambitious areas of growth.
The biggest strategic shift is the move into AI data centre infrastructure through GScale Energy, where Standard Engineering Technology has agreed to take up to a 51% stake. Management said the new unit is targeting ₹250 crore in revenue this fiscal year and is already in discussions with five customers, including three multinational companies and two Indian players. The company’s pitch is that it can supply the power, cooling and modular skid-mounted systems needed for modern data centres, while reducing build times from as long as 24 to 36 months to about 15 to 18 months. Business Standard reported earlier that the board approved a phased investment of about ₹500 crore across equity, capacity and working capital, with roughly ₹190 crore set aside for the first stage.
Alongside that push, the company has deepened its technical reach through a partnership with Japan’s JLACO, taking a 19% stake with an option to increase it to 51%. Management said the tie-up gives it access to glass-lining technologies that it claims are not currently made in India, including shell-and-tube glass heat exchangers, conductivity glass and high-corrosion-resistant materials designed for semiconductor-grade chemicals. The strategy is to preserve key intellectual property in Japan while manufacturing and assembling in India, a combination the company says could offer Japanese quality at Indian production costs. It also plans to take these products into Europe and the United States.
For the core business, management said it expects revenue of about ₹1,200 crore in fiscal 2027, supported by an order book of roughly ₹1,400 crore, with about half of that linked to contract development and manufacturing work for the pharmaceutical sector. The company also flagged a broader expansion pipeline, including a greenfield project and the addition of other end markets such as nuclear, oil and gas, flavours and fragrances. But the update also highlighted some pressures: exports were just 2% to 3% of revenue in the quarter because of weak global conditions and higher shipping costs, while EBITDA margin slipped to 17.5% as expenses rose. Management still expects margins to improve to 17% to 18% in the core business and 23% to 25% in GScale, but investors will be watching closely to see whether the new ventures can move from promise to execution.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
